Revvity, Inc. (RVTY)
99.09
+0.24
(+0.24%)
USD |
NYSE |
May 08, 09:30
Revvity Research and Development Expense (Annual) : 215.84M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Agilent Technologies, Inc. | 450.00M |
| Azenta, Inc. | 30.39M |
| Bruker Corp. | 395.20M |
| Avantor, Inc. | -- |
| Bio-Rad Laboratories, Inc. | 257.60M |